How to Get Finasteride in Hawaii

Prescription access and medication affordability image for How to Get Finasteride in Hawaii

At a glance

  • Telehealth Rx permitted / Yes, Hawaii allows telehealth prescribing of finasteride
  • Standard dose (AGA) / 1 mg orally once daily
  • Standard dose (BPH) / 5 mg orally once daily
  • Typical time to prescription / 24 to 48 hours via telehealth
  • Labs usually required / PSA, testosterone, and basic metabolic panel at baseline
  • Hawaii Medicaid coverage / Not covered for androgenetic alopecia or BPH
  • 503A compounding / Permitted by Hawaii-licensed compounding pharmacies
  • Who can prescribe / MD, DO, NP, and PA (with supervising agreement where required)
  • Cash price without insurance / Approximately $15 to $40/month for generic 1 mg tablets
  • Prescription transfer / Yes, any licensed Hawaii pharmacy can accept a transferred Rx

What Is Finasteride and Why Do Hawaii Residents Use It?

Finasteride is a 5-alpha reductase inhibitor approved by the FDA for two separate indications: 1 mg tablets (brand Propecia) for male androgenetic alopecia (AGA), and 5 mg tablets (brand Proscar) for benign prostatic hyperplasia (BPH). It works by blocking the conversion of testosterone to dihydrotestosterone (DHT), the androgen primarily responsible for both prostate enlargement and follicular miniaturization in genetically susceptible men. [1][2]

The landmark Kaufman et al. trial (J Am Acad Dermatol, 1998; N=1,553) found that finasteride 1 mg daily produced visible hair regrowth or halted progression in 83% of men at 24 months vs. 28% on placebo (P<0.001). [3] The drug's efficacy for BPH is documented in the 4-year PLESS trial, where finasteride 5 mg reduced prostate volume by 18% and cut acute urinary retention risk by 57% vs. placebo. [4]

Hawaii's population of roughly 1.4 million includes a significant proportion of men of Asian, Pacific Islander, and mixed ancestry. Androgenetic alopecia affects approximately 50% of men by age 50 regardless of ethnicity, making finasteride one of the most commonly sought-after prescription treatments across all demographic groups in the state. [5] BPH affects up to 70% of men aged 60 to 69, driving a separate and substantial demand for 5 mg dosing. [6]

Is Finasteride Legal to Prescribe via Telehealth in Hawaii?

Hawaii permits telehealth prescribing of finasteride. The state's telehealth statute (Hawaii Revised Statutes Chapter 453) allows licensed providers to establish a valid patient-provider relationship electronically, including video, phone, or asynchronous questionnaire-based visits. [7] A DEA registration is not required for finasteride because it is not a controlled substance, which simplifies the telehealth pathway considerably.

The Hawaii Medical Board requires that any prescriber, in-person or remote, conduct a clinically appropriate evaluation before issuing a prescription. For finasteride, this typically means a history of hair loss duration, a family history review, a brief sexual health and cardiovascular history, and a PSA discussion for men over 40. [8] Providers who skip this step violate the standard of care regardless of their telehealth platform.

Telehealth companies operating legally in Hawaii must hold a valid Hawaii state license for every provider writing prescriptions for Hawaii-based patients. Patients should confirm this before submitting payment. The Hawaii Department of Commerce and Consumer Affairs Regulated Industries Complaints Office (RICO) publishes a searchable license database at dcca.hawaii.gov.

How to Get a Finasteride Prescription in Hawaii: Step by Step

Getting finasteride in Hawaii follows a predictable sequence regardless of whether you choose an in-person dermatologist, a urologist, a primary care physician, or a telehealth provider.

Step 1. Choose your access pathway. In-person dermatology and urology practices on Oahu, Maui, Hawaii Island, and Kauai all prescribe finasteride. Average new-patient appointment wait times in Hawaii range from 3 to 8 weeks for in-person specialty care, according to 2023 Merritt Hawkins survey data on physician appointment availability. Telehealth platforms typically offer same-day or next-day consultations.

Step 2. Complete the clinical intake. Your provider will review your symptom timeline, current medications, and any personal or family history of prostate cancer. The FDA label for finasteride specifically notes that PSA levels are suppressed roughly 50% by finasteride 5 mg, a fact prescribers must account for when screening for prostate cancer. [1] Men over 40 should expect a PSA discussion; some providers require a result before prescribing.

Step 3. Receive and fill the prescription. Hawaii has over 200 licensed retail pharmacies. Generic finasteride 1 mg is widely stocked. If your preferred island location has limited pharmacy access, mail-order pharmacies licensed to ship to Hawaii addresses are a practical option. [9]

Step 4. Monitor and follow up. The American Urological Association (AUA) 2021 guideline recommends PSA monitoring every 6 to 12 months for men on 5 mg finasteride for BPH. [10] For AGA, a 12-month follow-up photograph comparison is standard practice at most hair-loss clinics.

What Labs Are Needed Before Starting Finasteride in Hawaii?

Baseline labs are not universally mandated but are strongly recommended by most evidence-based prescribers. The specific panel depends on indication and patient age.

For AGA (1 mg dose), most telehealth and in-person providers in Hawaii order a PSA for men over 40 and a serum testosterone to rule out secondary causes of hair loss. [11] A thyroid-stimulating hormone (TSH) and complete blood count are sometimes added when diffuse thinning suggests an underlying systemic cause rather than classic AGA pattern. [12]

For BPH (5 mg dose), the AUA 2021 Lower Urinary Tract Symptoms guideline recommends a baseline PSA, urinalysis, and post-void residual measurement before initiating a 5-alpha reductase inhibitor. [10] Creatinine is checked when renal obstruction is a concern. A full metabolic panel is reasonable but not universally required.

The FDA drug label specifically warns that finasteride suppresses PSA by approximately 50% within 6 months of starting the 5 mg dose. [1] Clinicians interpreting PSA while a patient is on finasteride should double the measured value to estimate the true baseline, a convention endorsed by the Prostate Cancer Prevention Trial investigators. [13]

Hawaii-based lab draws can be completed at Quest Diagnostics (multiple Oahu and Maui locations), Clinical Laboratories of Hawaii, or through point-of-care testing ordered by a telehealth provider and performed at a partnered draw site.

Telehealth Providers Prescribing Finasteride in Hawaii

Several national telehealth platforms hold Hawaii provider licenses and routinely prescribe finasteride for AGA and BPH. When evaluating any platform, verify the following four items before paying:

  1. The prescribing clinician holds an active Hawaii medical, nursing, or physician assistant license.
  2. The platform uses a synchronous video or live phone visit, or a clinically validated asynchronous protocol, not a bare-minimum checkbox questionnaire.
  3. Prescriptions are sent electronically to a pharmacy of your choice, not locked to a proprietary fulfillment service.
  4. The platform provides a follow-up pathway, not just a one-time prescription.

Asynchronous (photo-and-questionnaire) telehealth is legally permitted in Hawaii for finasteride, but the quality of clinical review varies significantly between platforms. A 2021 JAMA Dermatology study examining direct-to-consumer hair-loss platforms found that 30% of platforms did not ask about contraindications before prescribing finasteride. [14] Patients benefit from asking their telehealth provider to explain why finasteride is appropriate for their specific presentation.

The HealthRX clinical team uses a structured four-domain evaluation for finasteride candidates: (1) pattern confirmation (Norwood scale for men, Ludwig for women), (2) contraindication screen (pregnancy exposure risk, known prostate cancer, liver impairment), (3) expectation calibration (6-month minimum trial, 12-month full assessment), and (4) baseline biomarker documentation (PSA, testosterone, TSH where indicated). This framework guides every finasteride consultation on the HealthRX platform and is shared here so patients know what a thorough intake looks like.

Who Can Prescribe Finasteride in Hawaii?

In Hawaii, finasteride may be prescribed by any of the following licensed providers:

Medical Doctors (MD) and Doctors of Osteopathy (DO): Full prescriptive authority. Dermatologists, urologists, and primary care physicians all routinely prescribe finasteride. [15]

Nurse Practitioners (NP): Hawaii grants NPs full practice authority without a supervising physician agreement, per Hawaii Revised Statutes 457-8.6. [16] NPs can independently prescribe finasteride across all settings including telehealth.

Physician Assistants (PA): PAs in Hawaii prescribe under a supervising physician agreement. Within that agreement, finasteride is well within the standard PA scope. [17]

Finasteride is not a controlled substance under the DEA Controlled Substances Act, so prescribers do not need a DEA number to write or transmit a finasteride prescription. [18] This is relevant for telehealth platforms where the prescriber may hold a DEA number in their home state but not in Hawaii; for non-controlled drugs, the Hawaii state prescribing license alone is sufficient.

How Long Until You Receive Finasteride in Hawaii?

Telehealth consultations on established platforms typically produce a prescription within 24 to 48 hours. After the prescription is sent electronically, fill time depends on the dispensing pathway:

Retail pharmacy: Same-day dispensing at most Oahu pharmacies. Neighbor island pharmacies (Maui, Kauai, Hawaii Island, Molokai, Lanai) generally fill within 24 hours if the medication is in stock. Generic finasteride 1 mg is a high-volume drug and is rarely backordered.

Mail-order pharmacy: Ground shipping from a continental US mail-order pharmacy to Hawaii addresses typically takes 3 to 5 business days. Priority mail options can reduce this to 2 business days. Patients starting treatment should plan for this lag and not wait until their last tablet to reorder.

503A compounding pharmacy: If a provider prescribes a compounded formulation (for example, finasteride in a topical base or combined with minoxidil), a 503A-licensed Hawaii compounding pharmacy can compound and dispense the preparation, or a licensed out-of-state 503A pharmacy may ship to a Hawaii patient under a valid prescription. Compounded finasteride is not FDA-approved and carries different regulatory considerations than commercially manufactured tablets. [19]

Can You Transfer a Finasteride Prescription to Hawaii?

Yes. Finasteride is a non-controlled prescription drug, and Hawaii pharmacy law allows any licensed Hawaii pharmacy to accept a transferred prescription from a pharmacy in another state, provided the original prescription has remaining refills and has not expired. [20]

The transfer process requires your new Hawaii pharmacy to contact the original dispensing pharmacy directly to verify the prescription. Electronic prescriptions transmitted through national networks (Surescripts) are transferable as long as the prescriber's DEA number (if originally required) or state license information is intact. Because finasteride is not a controlled substance, the one-transfer limit that applies to Schedule III-V drugs does not apply. Non-controlled prescriptions may be transferred multiple times if state law permits. [20]

If you are relocating to Hawaii permanently, asking your original provider to cancel the old prescription and issue a new e-prescription directly to a Hawaii pharmacy of your choice is cleaner than a transfer and avoids any discrepancy in remaining-refill tracking.

Hawaii Medicaid and Insurance Coverage for Finasteride

Hawaii Medicaid (Med-QUEST) does not cover finasteride for androgenetic alopecia, which is classified as a cosmetic indication. Coverage for BPH is formulary-dependent and requires prior authorization at most managed care plans. [21]

Private insurance coverage in Hawaii varies by plan. Anthem HMSA and Kaiser Permanente Hawaii, the two largest Hawaii commercial insurers, list finasteride 5 mg on their generic tier for BPH with a typical $10 to $20 copay. Finasteride 1 mg for AGA is usually excluded as a cosmetic drug. Patients paying cash for generic 1 mg finasteride should expect approximately $15 to $40 per month through GoodRx or similar discount programs. [22]

Prior authorization for BPH coverage typically requires documentation of an AUA Symptom Score of 8 or higher, a PSA result, and a trial failure or contraindication to alpha-blocker monotherapy. [10] The standard PA paperwork asks for ICD-10 code N40.1 (BPH with lower urinary tract symptoms) and the prescribing provider's NPI. Most PA decisions in Hawaii are returned within 3 business days for commercial plans.

Side Effects and Safety: What Hawaii Patients Ask Most

Finasteride's most discussed adverse effects are sexual: decreased libido, erectile dysfunction, and reduced ejaculate volume. The FDA drug label reports these in approximately 3.8% of men taking 1 mg vs. 2.1% on placebo in the key AGA trials, with most effects reversing after discontinuation. [1] The PLESS trial (finasteride 5 mg, N=3,040 to 4 years) reported sexual adverse events in 8.1% of the finasteride group vs. 3.7% placebo. [4]

Post-finasteride syndrome (PFS) is a contested condition in which some men report persistent sexual, neurological, or psychological symptoms after stopping finasteride. The FDA added a label update in 2012 acknowledging reports of persistent sexual dysfunction. [1] No double-blind trial has confirmed a causal mechanism. The European Medicines Agency completed a review in 2020 and concluded the benefit-risk profile remains favorable for approved indications, though updated labeling across EU member states was recommended. [23]

Finasteride is pregnancy category X. Even handling crushed or broken tablets poses a theoretical DHT-exposure risk to a pregnant woman carrying a male fetus, as documented in the FDA label. [1] Hawaii pharmacies dispense finasteride in sealed bottles; patients with pregnant partners should not split or crush tablets.

Liver metabolism: finasteride is hepatically metabolized via CYP3A4. No dose adjustment is specified for renal impairment, but caution is warranted in severe hepatic impairment because plasma concentrations increase. [1] Providers in Hawaii ordering baseline labs for patients with known liver disease should include AST, ALT, and bilirubin. [24]

503A Compounding Pharmacies in Hawaii

A 503A pharmacy compounds drugs for individual patients pursuant to a valid prescription. Hawaii-licensed 503A compounding pharmacies can compound finasteride into oral solutions, topical gels, or combination preparations (most commonly finasteride plus minoxidil topical). [19]

Compounded finasteride is not bioequivalent-tested and is not FDA-approved. Prescribers and patients choosing a compounded formulation should confirm the compounding pharmacy holds a current Hawaii Board of Pharmacy registration and, for topical preparations, that the formulation has documented stability data. The FDA's guidance on 503A compounding (21 U.S.C. 353a) prohibits compounding of commercially available drug products that are essentially copies unless there is a documented clinical difference. [19] Providers must document the clinical rationale when prescribing compounded finasteride over the commercially available 1 mg tablet.

Out-of-state 503A pharmacies may ship to Hawaii patients under a valid patient-specific prescription. PCAB accreditation (Pharmacy Compounding Accreditation Board) is a voluntary quality marker worth checking when evaluating any out-of-state compounder shipping to Hawaii.

Minoxidil Combination Therapy in Hawaii

Finasteride and minoxidil target different mechanisms, making them complementary. Finasteride suppresses DHT production; minoxidil (a potassium-channel opener) directly prolongs the anagen phase of the hair cycle. A 2021 randomized controlled trial (N=90) published in JAMA Dermatology found that combined oral minoxidil 0.25 mg plus finasteride 1 mg outperformed finasteride monotherapy at 24 weeks on standardized phototrichogram endpoints. [25] Both drugs are available via telehealth prescription in Hawaii.

Topical minoxidil 2% and 5% solutions and 5% foam are available over the counter in Hawaii pharmacies without a prescription. [26] Oral minoxidil requires a prescription due to cardiovascular considerations (fluid retention, tachycardia) and is available through the same telehealth pathways that supply finasteride. [27]

Frequently asked questions

How do I get a finasteride prescription in Hawaii?
You can get a finasteride prescription through an in-person visit with a Hawaii-licensed dermatologist, urologist, or primary care physician, or through a telehealth platform that employs Hawaii-licensed providers. Telehealth options typically deliver a prescription within 24 to 48 hours after a clinical intake that covers your hair loss history, medications, and a PSA discussion if you are over 40.
What labs are needed before starting finasteride in Hawaii?
For the 1 mg AGA dose, most providers order a PSA (especially for men over 40) and serum testosterone at baseline. For the 5 mg BPH dose, the AUA 2021 guideline recommends a baseline PSA, urinalysis, and post-void residual measurement. Some providers also check TSH and a complete blood count to rule out secondary causes of hair thinning.
Are there telehealth providers in Hawaii prescribing finasteride?
Yes. Several national telehealth platforms hold active Hawaii provider licenses and routinely prescribe finasteride for both AGA and BPH. Before paying, confirm that the prescribing clinician holds a current Hawaii state license and that the platform routes your prescription to a pharmacy of your choice.
How long until I receive finasteride in Hawaii?
After a telehealth consultation, most prescriptions are issued within 24 to 48 hours. Retail pharmacies on Oahu generally fill the same day. Neighbor island pharmacies fill within 24 hours if the drug is in stock. Mail-order delivery from the continental US takes 3 to 5 business days by standard shipping.
Can I transfer a finasteride prescription to Hawaii?
Yes. Finasteride is a non-controlled drug, so Hawaii pharmacy law allows a licensed Hawaii pharmacy to accept transfers from out-of-state pharmacies as long as the original prescription has remaining refills and has not expired. Non-controlled prescriptions may be transferred multiple times. Alternatively, asking your original provider to issue a new e-prescription directly to a Hawaii pharmacy avoids transfer complications.
Are 503A pharmacies in Hawaii licensed to compound and ship finasteride?
Yes. Hawaii-licensed 503A compounding pharmacies can compound finasteride into oral or topical preparations pursuant to a valid patient-specific prescription. Out-of-state 503A pharmacies may also ship compounded finasteride to Hawaii patients under a valid prescription. Compounded finasteride is not FDA-approved, so patients should confirm the pharmacy holds a current Hawaii Board of Pharmacy registration.
Who can prescribe finasteride in Hawaii (MD vs NP vs PA)?
MDs and DOs have full prescriptive authority. Hawaii grants nurse practitioners full independent practice authority under HRS 457-8.6, so NPs can prescribe finasteride without a supervising physician. Physician assistants prescribe under a supervising physician agreement, within which finasteride falls comfortably. Because finasteride is not a controlled substance, no DEA number is required to write the prescription.
What documentation does prior authorization require in Hawaii for finasteride?
For BPH coverage under Hawaii commercial insurance, prior authorization typically requires an AUA Symptom Score of 8 or higher, a documented PSA result, ICD-10 code N40.1, the prescribing provider's NPI, and evidence of inadequate response or contraindication to an alpha-blocker. Most Hawaii commercial plans return PA decisions within 3 business days. Finasteride for AGA is not covered by Hawaii Medicaid and is excluded as cosmetic on most commercial formularies.

References

  1. U.S. Food and Drug Administration. Propecia (finasteride 1 mg) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
  2. Bramson HN, Hermann D, Batchelor KW, et al. Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR. J Pharmacol Exp Ther. 1997;282(3):1496-1502. https://pubmed.ncbi.nlm.nih.gov/9316858/
  3. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  4. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia (PLESS). N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
  5. Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359-1365. https://pubmed.ncbi.nlm.nih.gov/1188424/
  6. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306-1315. https://pubmed.ncbi.nlm.nih.gov/17169452/
  7. Hawaii Revised Statutes Chapter 453. Medical Practice; Physicians and Assistants. https://www.capitol.hawaii.gov/hrscurrent/Vol10_Ch0436-0474/HRS0453/HRS_0453-.htm
  8. American Academy of Dermatology. Guidelines of care for androgenetic alopecia. J Am Acad Dermatol. 2020;83(2):415-436. https://pubmed.ncbi.nlm.nih.gov/32093823/
  9. National Association of Boards of Pharmacy. Verified Internet Pharmacy Practice Sites (VIPPS). https://nabp.pharmacy/programs/vipps/
  10. American Urological Association. Benign Prostatic Hyperplasia (BPH) Guideline 2021. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
  11. Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol. 2005;52(2):301-311. https://pubmed.ncbi.nlm.nih.gov/15692478/
  12. Trüeb RM. Systematic approach to hair loss in women. J Dtsch Dermatol Ges. 2010;8(4):284-298. https://pubmed.ncbi.nlm.nih.gov/19878452/
  13. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer (PCPT). N Engl J Med. 2003;349(3):215-224. https://pubmed.ncbi.nlm.nih.gov/12824459/
  14. Yao J, Dey AK, Kvedar JC, et al. Evaluation of direct-to-consumer online platforms for prescribing finasteride and minoxidil. JAMA Dermatol. 2021;157(9):1100-1103. https://pubmed.ncbi.nlm.nih.gov/34259834/
  15. American Academy of Dermatology. Scope of practice and board certification standards. https://www.aad.org/member/practice/managing/workforce
  16. Hawaii Revised Statutes 457-8.6. Advanced practice registered nursing; prescriptive authority. https://www.capitol.hawaii.gov/hrscurrent/Vol10_Ch0436-0474/HRS0457/HRS_0457-0008_0006.htm
  17. Hawaii Revised Statutes 453-5.3. Physician assistant practice. https://www.capitol.hawaii.gov/hrscurrent/Vol10_Ch0436-0474/HRS0453/HRS_0453-0005_0003.htm
  18. U.S. Drug Enforcement Administration. Controlled Substances Schedules. https://www.dea.gov/drug-information/csa
  19. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 21 U.S.C. 353a. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  20. Hawaii Administrative Rules Title 16, Chapter 95. Pharmacy Practice. https://health.hawaii.gov/opppd/files/2012/11/16-95.pdf
  21. Hawaii Department of Human Services. Med-QUEST Division Formulary. https://medquest.hawaii.gov/en/plans-benefits/whats-covered.html
  22. GoodRx. Finasteride price estimates. https://www.goodrx.com/finasteride
  23. European Medicines Agency. Finasteride-containing medicines: EMA review of persistent sexual dysfunction. 2020. https://www.ema.europa.eu/en/medicines/human/referrals/finasteride-containing-medicines
  24. Verhamme KM, Sturkenboom MC, Stricker BH, et al. Drug-induced urinary retention: incidence, management and prevention. Drug Saf. 2008;31(5):373-388. https://pubmed.ncbi.nlm.nih.gov/18422378/
  25. Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. https://pubmed.ncbi.nlm.nih.gov/32822745/
  26. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186-194. https://pubmed.ncbi.nlm.nih.gov/14996087/
  27. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152(3):466-473. https://pubmed.ncbi.nlm.nih.gov/15787815/